401. Which relation most accurately captures the defining biological role of a production bioreactor?
ⓐ. Purified product + preservative + quality testing \(\to\) biological synthesis by living cells
ⓑ. Isolated DNA + restriction enzyme + ligase \(\to\) large-scale cell cultivation
ⓒ. Harvested culture + separation + purification \(\to\) growth of the production organism
ⓓ. Living production cells + supplied raw materials + controlled culture conditions \(\to\) biological product
Correct Answer: Living production cells + supplied raw materials + controlled culture conditions \(\to\) biological product
Explanation: A production bioreactor provides a controlled environment in which living cells use supplied raw materials to form the desired biological product. Conditions such as temperature, pH, substrate availability, salts, vitamins and oxygen can be regulated so that the production population remains physiologically active. Recombinant-DNA construction occurs before this scale-up stage, whereas recovery and purification occur after biosynthesis. The defining relation is therefore controlled biological conversion by living production cells rather than DNA manipulation or downstream processing.
402. Three bioreactor runs use the same recombinant cells:
| Run | pH | Temperature | Oxygen | Product output |
|---|
| P | Suitable | Suitable | Adequate | High |
| Q | Suitable | Suitable | Low | Reduced |
| R | Unsuitable | Suitable | Adequate | Reduced |
If the immediate objective is to isolate the effect of oxygen availability while keeping the listed pH and temperature conditions comparable, which comparison is most informative?
ⓐ. Q with R, because both have reduced product output despite differing in two listed conditions.
ⓑ. P with Q, because they differ in oxygen availability while the listed pH and temperature remain the same.
ⓒ. P with R, because oxygen is identical and pH differs between the two runs.
ⓓ. All three runs are equally suitable for isolating oxygen because controlled comparisons do not require other variables to be held comparable.
Correct Answer: P with Q, because they differ in oxygen availability while the listed pH and temperature remain the same.
Explanation: To evaluate the effect of one variable, the most informative comparison holds the other listed conditions as constant as possible. Runs P and Q share suitable pH and temperature and differ in oxygen availability, while product output also differs. P versus R instead isolates the listed pH change more directly, and Q versus R changes both pH and oxygen. The comparison therefore uses bioreactor data to separate the influence of oxygen from other controlled culture variables.
403. A stirred-tank bioreactor contains an efficiently functioning impeller but receives no sterile-air sparging. A second identical reactor has both stirring and sterile-air bubbling. If oxygen demand is high, which prediction is most reasonable?
ⓐ. Sterile-air sparging eliminates the need for mechanical agitation.
ⓑ. A non-sparged reactor must always contain more dissolved oxygen.
ⓒ. Sparging can increase gas-liquid contact area and improve oxygen transfer.
ⓓ. Air bubbles perform recovery and purification of the recombinant product.
Correct Answer: Sparging can increase gas-liquid contact area and improve oxygen transfer.
Explanation: Mechanical agitation distributes culture components and contributes to mixing, while sparging introduces sterile air as bubbles. Those bubbles increase the surface area across which oxygen can move from the gas phase into the culture medium. When oxygen demand is substantial, this additional gas-liquid interface can improve oxygen availability compared with mechanical stirring alone. The distinction is functional rather than merely structural.
404. A stirred-tank bioreactor has normal aeration and agitation, but the temperature-control system fails and the culture temperature moves far outside its suitable range. Which statement is best supported?
ⓐ. Adequate oxygen guarantees normal production even at an unsuitable temperature.
ⓑ. Temperature control is required only for agarose-gel electrophoresis.
ⓒ. Production may fall because cell activity requires a suitable temperature range.
ⓓ. Temperature failure automatically causes insertional inactivation of the vector.
Correct Answer: Production may fall because cell activity requires a suitable temperature range.
Explanation: Bioreactor performance depends on simultaneous control of several variables rather than on oxygen and mixing alone. Temperature strongly affects cellular and enzymatic activity, so movement outside the suitable range can reduce growth or recombinant-product formation even when other conditions remain appropriate. Reactor control systems therefore operate together to preserve a favourable production environment. Restoring temperature control is therefore necessary even when oxygen delivery and mixing remain adequate, because the culture depends on several controlled variables acting together.
405. A production vessel develops excessive foam only after aeration is increased. pH, temperature and nutrient levels remain suitable. Which response is most directly justified?
ⓐ. Adjust foam control while maintaining needed aeration and culture monitoring.
ⓑ. Remove the recombinant gene from the production host to eliminate foam formation.
ⓒ. Replace the mechanical agitator with a restriction endonuclease.
ⓓ. Stop downstream quality-control procedures until foam disappears.
Correct Answer: Adjust foam control while maintaining needed aeration and culture monitoring.
Explanation: Foam is a distinct physical problem that can arise during vigorous aeration and agitation. A dedicated foam-control system exists to manage this disturbance without unnecessarily altering successful molecular or physiological aspects of the process. Since pH, temperature and nutrient levels remain suitable, the most direct intervention is to correct the foam problem while preserving other conditions needed for production.
406. Samples from a bioreactor are withdrawn every hour. The sampling data show stable pH and temperature but a progressive fall in dissolved oxygen followed by a decline in product formation. Which interpretation is most reasonable?
ⓐ. The sampling schedule shows that DNA isolation is occurring inside the vessel.
ⓑ. Falling oxygen is most directly associated with the later decline in production.
ⓒ. Stable pH proves that oxygen availability cannot influence recombinant-product output.
ⓓ. The plasmid lost its cloning site at the same moment dissolved oxygen began to fall.
Correct Answer: Falling oxygen is most directly associated with the later decline in production.
Explanation: Sampling ports allow culture performance to be monitored over time without dismantling the entire production system. Here, product decline follows a measurable fall in oxygen while pH and temperature remain stable. This temporal relationship makes oxygen limitation the strongest identified process-level explanation. The observation illustrates the diagnostic value of monitoring multiple bioreactor variables rather than attributing every production problem to recombinant-DNA construction.
407. During a bioreactor run, pH control, aeration, agitation and foam control all function normally, but operators can no longer withdraw representative culture samples for periodic analysis. Which component has most directly failed?
ⓐ. Cloning site
ⓑ. DNA ligase
ⓒ. Restriction endonuclease
ⓓ. Sampling port
Correct Answer: Sampling port
Explanation: A sampling port allows portions of the culture to be withdrawn during operation so that cell growth, product formation or culture conditions can be monitored without dismantling the reactor. Failure of this access point specifically interferes with process monitoring, even if pH control, aeration, agitation and foam control remain functional. DNA ligase, restriction enzymes and cloning sites belong to recombinant-DNA construction and do not perform the physical sampling function of a production bioreactor.
408. A target protein has been synthesised inside recombinant cells, but most of it remains mixed with cellular material and culture-medium components. Which operation belongs immediately to the post-biosynthetic phase?
ⓐ. Recover and separate the target protein from harvested culture
ⓑ. Re-isolate the original donor gene from its genomic source
ⓒ. Repeat bacterial heat-shock transformation of the production host
ⓓ. Reconstruct the original recombinant plasmid before product recovery
Correct Answer: Recover and separate the target protein from harvested culture
Explanation: Once biosynthesis has produced the desired protein, biotechnology moves into downstream processing. The first broad objective is to recover or separate the target product from the complex biological mixture containing cells, medium and other molecules. Recombinant-DNA construction, transformation and gene isolation occur before production and therefore do not solve the post-biosynthetic recovery problem. Recovery may involve separating the target-containing fraction from cells or medium before finer purification removes remaining contaminants to the level required for final use.
409. A product has been separated from most of the culture material but still contains several unwanted molecules at concentrations unacceptable for final use. Which downstream objective remains incomplete?
ⓐ. Further transformation of host cells
ⓑ. Further purification of the product
ⓒ. Further PCR amplification of DNA
ⓓ. Further restriction digestion of DNA
Correct Answer: Further purification of the product
Explanation: Separation can recover the target product into a distinct fraction without necessarily removing every contaminant. Purification is the downstream stage that further removes unwanted substances so that the product reaches the required level of quality. The distinction matters because recovery and purification are related but not identical operations within downstream processing. Further purification is required before formulation or final quality assessment because the target fraction has been recovered but has not yet reached the required purity.
410. A purified recombinant product will lose stability during storage unless an appropriate preservative is incorporated into its final preparation. Which sequence is most logical?
ⓐ. biosynthesis \(\to\) recovery \(\to\) purification \(\to\) final formulation with preservative
ⓑ. formulation \(\to\) gene isolation \(\to\) restriction digestion \(\to\) transformation
ⓒ. clinical evaluation \(\to\) transformation \(\to\) PCR amplification \(\to\) gene isolation
ⓓ. DNA spooling \(\to\) micro-injection \(\to\) purification \(\to\) plasmid ligation
Correct Answer: biosynthesis \(\to\) recovery \(\to\) purification \(\to\) final formulation with preservative
Explanation: The product must first be biologically produced and then sufficiently purified before it is prepared in its final usable form. Formulation can include suitable preservatives or other components needed for storage, handling or application. This places formulation downstream of purification rather than before recombinant-DNA construction or host transformation. The preservative supports stability of the finished preparation; it does not replace the earlier purification needed to remove unwanted biological material.
411. Consider the following statements:
I. Downstream processing begins after the desired product has been biosynthesised.
II. Separation and purification are downstream operations.
III. Every biotechnology product must undergo exactly the same formulation and clinical-testing procedure.
IV. Quality control depends on the nature and intended use of the finished product.
Which option is correct?
ⓐ. I and III only
ⓑ. II and III only
ⓒ. I, II and IV only
ⓓ. I, II, III and IV
Correct Answer: I, II and IV only
Explanation: Downstream processing starts after biosynthesis and includes product recovery, separation and purification. Quality-control requirements are also product-specific because different products differ in composition and intended use. Statement III is incorrect because downstream procedures, formulation requirements and clinical evaluation are not identical for every biotechnology product. Therapeutic drug formulations have requirements that should not be generalised to all other products.
412. A recombinant therapeutic drug has completed appropriate clinical evaluation, but final quality-control testing of the current manufactured lot detects an unacceptable contaminant. Which conclusion is most appropriate?
ⓐ. The lot should not be released because clinical evaluation does not replace product-specific final quality control.
ⓑ. The lot is acceptable because clinical evaluation makes final purity and quality testing unnecessary.
ⓒ. The contaminant can be disregarded if recombinant expression and formulation were completed successfully.
ⓓ. Repeating clinical evaluation alone is sufficient even if the contaminant remains in the manufactured lot.
Correct Answer: The lot should not be released because clinical evaluation does not replace product-specific final quality control.
Explanation: Clinical evaluation and final product-quality assessment address different requirements. Appropriate clinical evaluation is important for therapeutic use, but each manufactured product must still meet the quality standards relevant to its final preparation. Detection of an unacceptable contaminant indicates that the current lot has not satisfied those requirements, even if the therapeutic product has previously undergone clinical evaluation. Successful gene expression or earlier production steps cannot substitute for adequate downstream purification and final quality control.
413. Two finished biotechnology products pass their respective purification procedures, but one fails its product-specific quality-control test. Which conclusion is most appropriate?
ⓐ. Quality-control testing is unnecessary once formulation has occurred.
ⓑ. Purification and quality control are the same downstream operation.
ⓒ. Quality-control failure proves that recombinant DNA was never constructed.
ⓓ. Purification does not guarantee that all final quality requirements are met.
Correct Answer: Purification does not guarantee that all final quality requirements are met.
Explanation: Purification removes unwanted material and improves product quality, but final release can depend on additional product-specific standards. Quality control evaluates whether the finished biotechnology product satisfies those required criteria. Failure at this stage therefore identifies a problem with final product suitability or consistency rather than automatically invalidating all earlier stages of recombinant-DNA construction and production. Quality control evaluates whether the final preparation satisfies all relevant specifications, so failure at this stage can require additional purification, reformulation or other product-specific correction.
414. A facility produces a recombinant enzyme for industrial use and a recombinant therapeutic protein for medical use. Which statement best distinguishes their downstream requirements?
ⓐ. Only the therapeutic protein requires recovery and purification because industrial enzymes are used directly from the culture.
ⓑ. Both require suitable recovery and purification, but the therapeutic product may additionally require clinical evaluation appropriate to medical use.
ⓒ. Both must undergo identical clinical evaluation because recombinant DNA was used to produce them.
ⓓ. Neither requires product-specific quality control once recombinant expression has been confirmed.
Correct Answer: Both require suitable recovery and purification, but the therapeutic product may additionally require clinical evaluation appropriate to medical use.
Explanation: Successful recombinant expression is followed by downstream recovery and purification of the desired product, regardless of whether the product is ultimately used industrially or therapeutically. Final requirements then diverge according to product nature and intended use. A therapeutic drug formulation requires appropriate clinical evaluation before administration, whereas an industrial enzyme should be assessed under requirements suited to its own use. Thus recombinant origin creates a shared production background but does not make all final downstream pathways identical.
415. A biotechnology production line gives the following evidence:
| Checkpoint | Observation |
|---|
| P | Correct recombinant construct confirmed |
| Q | Host expresses the desired protein |
| R | Bioreactor output is high |
| S | Recovered product remains heavily contaminated |
Which intervention is most directly indicated?
ⓐ. Redesign PCR primers even though the recombinant construct is already correct.
ⓑ. Improve downstream recovery and purification of the contaminated product.
ⓒ. Repeat heat-shock transformation despite confirmed expression in the host.
ⓓ. Remove the functional ori from the successfully producing recombinant vector.
Correct Answer: Improve downstream recovery and purification of the contaminated product.
Explanation: Evidence at P, Q and R shows success of recombinant construction, expression and large-scale production. The unresolved defect appears only after recovery, where the product still contains excessive contaminants. The most direct intervention therefore lies in downstream separation and purification rather than in restarting earlier molecular stages that have already been demonstrated to work. Because the defect appears only after high-yield production, changing the recombinant construct or restarting transformation would not address the evidence-based location of the failure.
416. A production process is summarised as:
P. Target DNA amplified in vitro.
Q. Amplified DNA ligated into a suitable vector.
R. Recombinant vector introduced into a competent host.
S. Desired protein produced by the host.
T. Production expanded in a controlled bioreactor.
U. Product recovered, purified and formulated.
Which statement best integrates the complete pathway?
ⓐ. P amplifies target DNA, Q constructs recombinant DNA, R establishes the recombinant host, S-T produce and scale the product, and U is downstream processing.
ⓑ. P constructs recombinant DNA, Q amplifies it by thermal cycling, R purifies the DNA, S transforms the host, and T-U complete gene expression.
ⓒ. P-Q represent downstream processing, R-S recover the final product, and T-U perform the molecular construction of recombinant DNA.
ⓓ. P-R are stages of protein purification, S introduces recombinant DNA into the host, and T-U perform restriction digestion and ligation.
Correct Answer: P amplifies target DNA, Q constructs recombinant DNA, R establishes the recombinant host, S-T produce and scale the product, and U is downstream processing.
Explanation: Each stage performs a distinct role in the recombinant-production pathway. At P, PCR increases the amount of target DNA in vitro. At Q, the amplified DNA is joined to a suitable vector, producing the recombinant DNA construct. At R, the recombinant vector is introduced into a competent host. Expression of the foreign gene at S produces the desired protein, and controlled cultivation at T expands production to a useful scale. Stage U occurs after biosynthesis and represents downstream processing, including recovery, purification and formulation of the product.
417. A laboratory has successfully completed DNA isolation, restriction digestion, fragment recovery and ligation. However, the recombinant vector is never introduced into any recipient cell. Which later outcome is therefore most directly blocked?
ⓐ. Recognition of the target restriction site by the enzyme during digestion
ⓑ. Formation of compatible sticky ends during earlier restriction digestion
ⓒ. Elution of the desired DNA fragment from the previously excised gel band
ⓓ. Stable host-based propagation and expression of the recombinant construct
Correct Answer: Stable host-based propagation and expression of the recombinant construct
Explanation: The recombinant DNA molecule has already been constructed, so the earlier molecular steps have succeeded. Without transfer into an appropriate host, however, the recombinant construct cannot be biologically propagated through host growth or expressed to produce the desired protein. This shows why recombinant-DNA technology does not end with ligation; host introduction is the bridge between DNA construction and biological production.
418. A host cell contains a recombinant plasmid and produces the desired protein, but the production vessel is too small to meet demand. Which pair of stages has already succeeded?
ⓐ. Bioreactor scale-up and final quality control
ⓑ. Downstream purification and therapeutic clinical evaluation
ⓒ. DNA precipitation and final product formulation
ⓓ. Host transformation and recombinant-gene expression
Correct Answer: Host transformation and recombinant-gene expression
Explanation: The presence of recombinant plasmid DNA shows that the host has received and maintained the construct, while production of the desired protein demonstrates expression. The remaining limitation is scale rather than recombinant construction. This distinction prevents unnecessary repetition of earlier molecular steps when the actual problem is insufficient production capacity. The next limitation is therefore production capacity: scale-up should increase the amount generated while preserving the already demonstrated recombinant-host and expression functions.
419. A bioreactor contains the correct recombinant host, but product output decreases when oxygen supply is reduced and returns toward its previous level when oxygen delivery is restored. Which type of evidence is this?
ⓐ. Evidence that oxygen availability affects production in the bioreactor
ⓑ. Evidence that the vector lacks a functional selectable marker
ⓒ. Evidence that PCR primer sequences mutated during culture growth
ⓓ. Evidence that downstream purification takes place within the bioreactor
Correct Answer: Evidence that oxygen availability affects production in the bioreactor
Explanation: The same recombinant host is present throughout the experiment, while oxygen availability is deliberately altered and product output changes in parallel. Restoration of oxygen is followed by recovery of production, supporting a process-level relationship between oxygen availability and biological performance. This illustrates how bioreactor control variables can directly influence yield without any change in the recombinant genotype. The reversibility strengthens the inference because changing the oxygen variable in opposite directions is followed by corresponding changes in product output while the recombinant host remains the same.
420. A finished recombinant product has been purified, formulated and found to meet all applicable quality standards for its intended non-therapeutic use. Which general conclusion is most appropriate?
ⓐ. The finished product must return to transformation before it can be released.
ⓑ. The product still requires clinical trials because all biotechnology products follow identical pathways.
ⓒ. The product has reached a suitable product-specific downstream endpoint without therapeutic-only steps.
ⓓ. Quality control is unnecessary for any product once formulation is complete.
Correct Answer: The product has reached a suitable product-specific downstream endpoint without therapeutic-only steps.
Explanation: Downstream processing is determined by the nature and intended use of the product. A non-therapeutic biotechnology product can complete its appropriate recovery, purification, formulation and quality-control requirements without automatically following the same clinical-evaluation pathway required for relevant therapeutic drugs. The important principle is product-specific finishing and assessment rather than one universal downstream protocol. This illustrates why downstream endpoints are product-specific: a non-therapeutic product need not acquire therapeutic-only steps once its own applicable processing and quality requirements have been satisfied.
